Cornus Mas L improves Antioxidant Status in the Liver, Lung, Kidney, Testis and Brain of Ehrlich Ascites Tumor Bearing Mice

Document Type : Research Articles

Authors

1 Department of Anatomy, Yozgat Bozok University Faculty of Medicine, Yozgat, Turkey.

2 Department of Biochemistry, Yozgat Bozok University Faculty of Medicine, Yozgat, Turkey.

3 Department of Molecular Biology and Genetics, Gebze Technical University, Kocaeli Turkey.

Abstract

Cornelian Cherry (Cornus Mas L) has widespread use due to its anti-inflammatory, anti-carcinogenic and anti-oxidant properties. In this study, the effects of Cornus Mas L (C. mas L) in different dosages on the biochemical values of mice organs were investigated in the Ehrlich Ascites tumor model, which originated from mice breast adenocarcinoma and developed in Balb/C mice. In our study, 32 Balb/C type male mice were used. Ehrlich Ascites Tumor (EAT) cells (1x106 EAT cell) from the stock animal were injected into all the mice in an intraperitoneal way. Experimental groups were given 100 and 200mg/kg C. mas L extract intraperitoneally for 9 days. The weights of the animals were recorded every day and were sacrificed on the 9th day. To estimate tumor proliferation of the lung, brain, kidney, liver, and testis, antioxidant parameters were recorded including, the reduced glutathione (GSH), lipid peroxidation, glutathione S-transferase (GST), superoxide dismutase (SOD) and catalase (CAT). Treatments of different doses of C. mas L. meaningfully (p < 0.05) modulated the lung, brain, kidney, liver and testis tissues antioxidant parameters as compared to the control. Our study showed the anti-tumor effect of C. mas L. in assisted tumor development with EAT cells, conceivably moderated by the enhancement of oxidative stress due to numerous mechanisms.
 

Keywords

Main Subjects


Volume 21, Issue 9
September 2020
Pages 2531-2537
  • Receive Date: 20 June 2019
  • Revise Date: 03 June 2020
  • Accept Date: 12 September 2020
  • First Publish Date: 12 September 2020